Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,333,749 papers from all fields of science
Search
Sign In
Create Free Account
Pharmacoeconomic Study
Known as:
PHARMACOECONOMIC
A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
CDISC SDTM Trial Type Terminology
Clinical Data Interchange Standards Consortium Terminology
Economics, Pharmaceutical
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Economic analyses in squamous cell carcinoma of the head and neck: a review of the literature from a clinical perspective.
J. D. de Souza
,
I. Santana
,
G. de Castro
,
G. de Lima Lopes
,
Ya-Chen Tina Shih
International Journal of Radiation Oncology…
2014
Corpus ID: 7372995
Review
2012
Review
2012
Assessing the Quality of Pharmacoeconomic Studies in India
P. Desai
,
H. Chandwani
,
K. Rascati
PharmacoEconomics (Auckland)
2012
Corpus ID: 5364001
AbstractObjective: The aim of the study was to evaluate the quality of pharmacoeconomic studies based in India. Methods: A…
Expand
2012
2012
A Case for the Adoption of Pharmacoeconomic Guidelines in Japan
S. Ikeda
,
N. Ikegami
,
A. Oliver
,
M. Ikeda
PharmacoEconomics (Auckland)
2012
Corpus ID: 19505436
In recent years, more and more Japanese pharmaceutical companies have been submitting pharmacoeconomic data to the government…
Expand
2002
2002
Pharmacoeconomic and clinical outcomes in oncology using oral chemotherapy.
R. Navarro
,
T. Morrow
,
R. Baran
Managed care interface
2002
Corpus ID: 19552185
Oral dosage forms are the most common mode of drug delivery in most disease areas. However, cancer therapy is associated…
Expand
1998
1998
Pharmacoeconomic Analysis in New Drug Development: A Pragmatic Approach to Efficiency Studies
C. Terrés
1998
Corpus ID: 71649061
AbstractExplanatory clinical trials do not have the most suitable design to evaluate the impact of a new pharmaceutical product…
Expand
Review
1998
Review
1998
Pharmacoeconomic Education in U.S. Schools of Pharmacy
K. Rascati
,
T. Conner
,
J. Draugalis
American Journal of Pharmaceutical Education
1998
Corpus ID: 80127671
Highly Cited
1996
Highly Cited
1996
Pharmacoeconomic analysis of smoking-cessation interventions.
W. Mcghan
,
Marilyn Dix Smith
American Journal of Health-System Pharmacy
1996
Corpus ID: 23558534
A model for evaluating the costs and benefits of smoking-cessation interventions is proposed and published data on the subject…
Expand
Review
1996
Review
1996
A Strategy for Collecting Pharmacoeconomic Data During Phase II/III Clinical Trials
J. Mauskopf
,
K. Schulman
,
Larry Bell
,
H. Glick
PharmacoEconomics (Auckland)
1996
Corpus ID: 37494947
SummaryThis article presents an overview of the process and organisational aspects required to support the collection of…
Expand
1993
1993
Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.
Skaer Tl
1993
Corpus ID: 77949264
P & T Committees were established as an institution's primary organizational tool for the development and maintenance of the…
Expand
Review
1992
Review
1992
Interpreting Pharmacoeconomic and Quality-of-Life Clinical Trial Data for Use in Therapeutics
M. Testa
,
W. Lenderking
PharmacoEconomics (Auckland)
1992
Corpus ID: 20823797
SummaryInterpretation of quality-of-life (QOL) and pharmacoeconomic data for therapeutic decision making and therapeutic policy…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE